Financial Data and Key Metrics Changes - Total revenues increased by 5% year on year to 7,400,000,000 pesos, reflecting growth across operations, particularly in Puerto Rico and Colombia [7][8] - Consolidated EBITDA rose slightly by 2% year on year, reaching 5,000,000 pesos, with Puerto Rico and Colombia posting double-digit growth [12] - The adjusted EBITDA margin, excluding construction revenue, stood at nearly 68%, down from 69% in the same quarter last year [12] Business Line Data and Key Metrics Changes - Mexico, accounting for 72% of total revenues, posted a low single-digit increase of 0.7% in revenues, with growth in both aeronautical and non-aeronautical revenues [8] - Puerto Rico contributed 17.7% of total revenues with high teens growth, while Colombia, accounting for 12% of total revenues, posted 15.4% growth [8][9] - Commercial revenue per passenger reached nearly 140 pesos, representing mid-single-digit year-on-year growth, with Colombia leading at a 22% increase [10] Market Data and Key Metrics Changes - Passenger traffic remained largely flat year on year at 17,700,000, with Puerto Rico showing 3% growth, while Mexico reported a decline of nearly 2% [4][5] - International travel in Mexico saw declines from all regions, with Europe down 4.7%, the US down 5.3%, and South America down 2.7% [5] - A significant portion of the decline in international traffic, approximately 38%, is attributed to the new airport in Tulum [5] Company Strategy and Development Direction - The company continues to invest in infrastructure and expand commercial offerings, having opened 47 new commercial spaces over the last twelve months [9] - The strategy includes modernization and expansion projects at Mexican airports, with ongoing work at Lincoln Airport and taxiway hotels in Puerto Rico [15] - The company remains focused on long-term growth potential despite current market uncertainties [6][16] Management's Comments on Operating Environment and Future Outlook - Management expects traffic in Mexico to gradually stabilize over the next year as operational issues related to aircraft are resolved [6] - The company does not anticipate a material impact from potential US Department of Transportation restrictions on Mexican carriers [6] - Management expressed confidence that travel-related disruptions are typically temporary and that the company is well-positioned to mitigate risks [16] Other Important Information - The company closed the quarter with nearly 20,000,000,000 pesos in cash and cash equivalents, up 30% year on year [13] - A foreign exchange loss of 1,200,000,000 pesos negatively impacted the bottom line, contrasting with a gain of 942,000,000 pesos in the same quarter last year [13] Q&A Session Summary Question: What drove the sequential decline in non-air revenues? - Management indicated that exchange rates played a significant role, along with a slight difference in passenger mix and issues at Terminal 2 [20][22] Question: What impact could lifted capacity restrictions in Mexico City have? - Management noted that an increase in operations at Mexico City Airport could benefit overall passenger traffic, but expressed doubts about significant changes occurring soon [21][24] Question: What is the current traffic situation at Tulum Airport? - Most traffic at Tulum is still primarily commercial flights from the US, with some domestic traffic [27][30] Question: What is the outlook for traffic growth in the second half of the year? - Management expects some normalization in traffic, with potential single-digit growth anticipated compared to the second half of 2024 [34][36] Question: What is the rationale behind the new debt? - The new debt is related to tax expenses at Cancun Airport, ensuring sufficient cash for future dividend payments [60][61] Question: What are the dynamics of international traffic in Puerto Rico and Colombia? - Growth in Puerto Rico is driven by events and concerts, while Colombia's growth is primarily linked to travel from the US [84]

Second Quarter 2025 Performance July 23, 2025 Important Notice to Investors Please read this management presentation together with the Company's press release issued earlier today announcing the Company's second quarter 2025 financial results and in conjunction with the Company's recent Annual Report and Quarterly Reports as filed with the Securities and Exchange Commission (SEC). Certain statements contained in this presentation that are not historical facts may be forward looking statements within the mea ...

Financial Performance - Net income for Q2 2025 was $210 million, an increase of $32 million compared to Q1 2025 and Q2 2024[8] - Net interest income increased by $26 million to $632 million[8, 24] - Earnings per share (EPS) increased by $053 to $309[8] - Return on average tangible common equity (ROTCE) was 1326%[8] Balance Sheet - Loans held in portfolio grew by $931 million or 25%[8, 10] - Total deposits increased by $14 billion or 21%[10] - Tangible book value per share increased by $339 to $7541[8, 10] - Total assets reached $76065 million[8] Credit Quality - Non-performing loans (NPLs) decreased by $2 million to $312 million[8, 10] - NPL ratio improved to 082% compared to 084% in Q1 2025[8, 10] - Net charge-off (NCO) ratio was 045% compared to 053% in Q1 2025[8, 10] Capital Actions - The company repurchased $1120 million in common stock at an average price of $9854 per share[10, 44] - A new common stock repurchase program of up to $500 million was announced[10, 44]

Financial Data and Key Metrics Changes - For Q2 2025, the company reported a GAAP net loss of $35 million, or negative $0.53 per share, with a book value per share of $13.84 as of June 30, 2025 [3] - The distributable loss was $3 million, primarily due to taking ownership of the West Hollywood property, while prior to realized losses, distributable earnings were $16 million, or $0.24 per share [3][4] - A cash dividend of $0.25 was paid for the second quarter [4] Business Line Data and Key Metrics Changes - Originations in the quarter totaled $211 million, consisting of two loans secured by industrial and multifamily properties [7] - The company had two full repayments and six partial repayments totaling $450 million, with projections of nearly $1 billion in incremental repayments over the second half of the year [7] - The company downgraded a Boston Life Science asset from a four-rated loan to a five-rated loan and a Chicago office loan from a three-rated loan to a four-rated loan due to market deterioration [8][9] Market Data and Key Metrics Changes - The real estate credit market has seen a recovery in transaction activity and loan demand, with significant opportunities in the loan pipeline [5] - Competition has returned, with most lenders active in the market, leading to attractive lending opportunities driven by the ability to lend on reset values below replacement costs [6] - The Life Science sector represents 12% of the portfolio, with 60% of the assets being newly constructed and purpose-built properties targeting larger pharmaceutical tenants [10] Company Strategy and Development Direction - The company is focusing on diversifying its portfolio geographically into Europe and creating more duration through CMBS investments [7] - An active pipeline in the European loan market is anticipated, with new originations expected by the end of the year [7] - The company aims to maximize shareholder value through proactive management of the portfolio and capital allocation across share buybacks and loan origination [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the lending opportunity remaining highly attractive despite competition, with healthy fundamentals across most property types [6] - The company is closely monitoring leverage ratios and expects to match repayments with new originations [26] - Management noted that many borrowers are pulling financing forward to buy time for asset recovery, indicating a positive outlook for rental increases and property values [33] Other Important Information - The company repurchased $20 million of KREF stock in Q2 at a weighted average price of $9.21, with nearly $40 million repurchased over the last three quarters [15] - At quarter-end, the company had $757 million of liquidity available, including $108 million in cash and $620 million of undrawn corporate revolver capacity [16] Q&A Session Summary Question: Can you talk about the level of ROEs and loan spreads in the current market? - Management indicated that the pipeline is robust, with ROEs in the mid-11s to end of the 13s, and loan spreads have compressed back to pre-tariff levels [20][25] Question: What kind of originations do you expect in the second half? - Management expects to actively originate loans to match the anticipated $1 billion in repayments, with no significant near-term maturities on the radar [26][27] Question: Can you provide insight into the 2026 maturity wall? - Management noted that many maturities are being pulled forward, and they expect less credit issues around maturities as most problems have already surfaced [30][34] Question: How do you differentiate between refinancing and extensions? - The majority of refinancings are new credits, while modifications and extensions are less common, indicating a focus on new opportunities [39] Question: What is the timeline for repatriating capital from the REO portfolio? - Management provided a timeline for various assets, indicating that some could see capital repatriation within 12 to 18 months, while others may take longer [79][87]

Freeport-McMoRan (FCX) Q2 2025 Earnings Call July 23, 2025 10:00 AM ET Speaker0Ladies and gentlemen, thank you for standing by. Welcome to the Freeport McMoran Second Quarter Conference Call. I would now like to turn the conference over to Mr. David Joint, Vice President, Investor Relations. Please go ahead, sir.Speaker1Good morning, everyone, and welcome to the Freeport conference call. Earlier this morning, FCX reported its second quarter twenty twenty five operating and financial results. A copy of today ...

VERTUS LAUNCHES BLOCKCHAIN-BASED PLATFORM FOR STRUCTURED CREDIT ON THE XRP LEDGER- One of Brazil’s top financial service firms, @THE_VERTUS, has launched a blockchain-based platform for structured credit, with a debut transaction valued at BRL 700 million (USD 130 million), built on the @Ripple XRP Ledger (XRPL).- The newly unveiled platform is designed to mirror private credit operations and fund activities onchain, making key financial events traceable and transparent in real time.Key Details:- The platfo ...

Three months ago, Ray, you said that we were about three years away from the US going broke. A lot has changed since then. The tariffs, liberation day, the markets, no spasms from that.And Moody's downgraded the US debt. They were the third of the ratings agencies to do so. How close are we now, if not 3 years away.>> Well, it really depends on how we're going to deal with this. We are at a juncture right now. If we can soon, very soon, while the economy is still good, cut the deficit to 3% of GDP, which is ...

Based founders. Based community. Based ecosystem.Built for Ethereum. Built for Bitcoin.Built to last.StarkWare 🐺🐱 (@StarkWareLtd):Starknet has the most cypherpunk origin story of any L2 founder.In 2013, @EliBenSasson was already on stage presenting ZK as a way to scale Bitcoin.12 years later, the vision is coming full circle: ZK is reaching Bitcoin, and you can already build with it. https://t.co/btltghALoz ...

If you've ever played the New York Times Connections game, you know it can be challenging. That said it. What.How do I mix it up. The game's notoriety was recently part of a joke on Saturday Night Live. So this order will make the New York Times Connections game easier.And it's about time. Every time it's like, how the hell was I going to get that fourth one. Of course, this isn't a video about connections.This is about how President Trump has been using executive orders to reshape government and society in ...

Core Viewpoint - Securities class action lawsuits have been filed against Hims & Hers Health, Inc. for allegedly making false and misleading statements regarding the company's business practices and safety concerns related to its products [1][2]. Allegations Against Hims & Hers - The complaints allege that Hims & Hers engaged in deceptive promotion and selling of illegitimate versions of Wegovy, which posed risks to patient safety [2]. - It is claimed that there was a substantial risk of termination of Hims & Hers' collaboration with Novo Nordisk due to these practices [2]. - The positive statements made by the company regarding its business and prospects were allegedly materially misleading and lacked a reasonable basis [2]. Lead Plaintiff Process - Investors in Hims & Hers have until August 25, 2025, to seek appointment as a lead plaintiff representative of the class [3]. - The lead plaintiff will act on behalf of all class members and select counsel to represent the class in the litigation [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [4].